VERACYTE INC (VCYT) Fundamental Analysis & Valuation

NASDAQ:VCYT • US92337F1075

Current stock price

33.8 USD
+0.77 (+2.33%)
At close:
33.8 USD
0 (0%)
After Hours:

This VCYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. VCYT Profitability Analysis

1.1 Basic Checks

  • VCYT had positive earnings in the past year.
  • VCYT had a positive operating cash flow in the past year.
  • In multiple years VCYT reported negative net income over the last 5 years.
  • VCYT had a positive operating cash flow in 4 of the past 5 years.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • VCYT has a Return On Assets of 4.72%. This is amongst the best in the industry. VCYT outperforms 90.70% of its industry peers.
  • VCYT has a better Return On Equity (5.07%) than 90.70% of its industry peers.
  • VCYT has a Return On Invested Capital of 4.59%. This is amongst the best in the industry. VCYT outperforms 90.31% of its industry peers.
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROIC 4.59%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin of VCYT (12.83%) is better than 91.67% of its industry peers.
  • VCYT has a Operating Margin of 15.14%. This is amongst the best in the industry. VCYT outperforms 92.05% of its industry peers.
  • With an excellent Gross Margin value of 70.10%, VCYT belongs to the best of the industry, outperforming 80.62% of the companies in the same industry.
  • VCYT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

8

2. VCYT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
  • The number of shares outstanding for VCYT has been increased compared to 1 year ago.
  • The number of shares outstanding for VCYT has been increased compared to 5 years ago.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • VCYT has an Altman-Z score of 16.87. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 16.87, VCYT belongs to the top of the industry, outperforming 86.05% of the companies in the same industry.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.87
ROIC/WACC0.5
WACC9.19%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 8.15 indicates that VCYT has no problem at all paying its short term obligations.
  • VCYT's Current ratio of 8.15 is fine compared to the rest of the industry. VCYT outperforms 72.29% of its industry peers.
  • A Quick Ratio of 7.81 indicates that VCYT has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 7.81, VCYT is doing good in the industry, outperforming 70.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.15
Quick Ratio 7.81
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. VCYT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 176.67% over the past year.
  • Looking at the last year, VCYT shows a quite strong growth in Revenue. The Revenue has grown by 16.01% in the last year.
  • The Revenue has been growing by 34.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.22% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, VCYT will show a quite strong growth in Revenue. The Revenue will grow by 10.74% on average per year.
EPS Next Y27.72%
EPS Next 2Y22.38%
EPS Next 3Y19.54%
EPS Next 5Y21.22%
Revenue Next Year13.07%
Revenue Next 2Y12.7%
Revenue Next 3Y11.91%
Revenue Next 5Y10.74%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

5

4. VCYT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 40.72 indicates a quite expensive valuation of VCYT.
  • 91.09% of the companies in the same industry are more expensive than VCYT, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.87, VCYT is valued a bit more expensive.
  • VCYT is valuated quite expensively with a Price/Forward Earnings ratio of 31.89.
  • Based on the Price/Forward Earnings ratio, VCYT is valued cheaper than 92.83% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of VCYT to the average of the S&P500 Index (38.51), we can say VCYT is valued inline with the index average.
Industry RankSector Rank
PE 40.72
Fwd PE 31.89
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • 92.25% of the companies in the same industry are more expensive than VCYT, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 95.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.21
EV/EBITDA 21.68
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of VCYT may justify a higher PE ratio.
  • VCYT's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.47
PEG (5Y)N/A
EPS Next 2Y22.38%
EPS Next 3Y19.54%

0

5. VCYT Dividend Analysis

5.1 Amount

  • No dividends for VCYT!.
Industry RankSector Rank
Dividend Yield 0%

VCYT Fundamentals: All Metrics, Ratios and Statistics

VERACYTE INC

NASDAQ:VCYT (4/17/2026, 8:00:02 PM)

After market: 33.8 0 (0%)

33.8

+0.77 (+2.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners110.9%
Inst Owner Change-0.01%
Ins Owners0.91%
Ins Owner Change6.62%
Market Cap2.69B
Revenue(TTM)517.14M
Net Income(TTM)66.35M
Analysts82.11
Price Target49.52 (46.51%)
Short Float %8.05%
Short Ratio6.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.79%
Min EPS beat(2)79.03%
Max EPS beat(2)132.56%
EPS beat(4)3
Avg EPS beat(4)43.36%
Min EPS beat(4)-110.32%
Max EPS beat(4)132.56%
EPS beat(8)6
Avg EPS beat(8)164.25%
EPS beat(12)8
Avg EPS beat(12)72.71%
EPS beat(16)12
Avg EPS beat(16)65.75%
Revenue beat(2)2
Avg Revenue beat(2)3.25%
Min Revenue beat(2)3.19%
Max Revenue beat(2)3.31%
Revenue beat(4)4
Avg Revenue beat(4)3.32%
Min Revenue beat(4)1.01%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)3.84%
Revenue beat(12)11
Avg Revenue beat(12)4.44%
Revenue beat(16)15
Avg Revenue beat(16)5.09%
PT rev (1m)-1.29%
PT rev (3m)0.38%
EPS NQ rev (1m)1.88%
EPS NQ rev (3m)-21.3%
EPS NY rev (1m)-8.37%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)2.43%
Valuation
Industry RankSector Rank
PE 40.72
Fwd PE 31.89
P/S 5.19
P/FCF 21.21
P/OCF 19.7
P/B 2.05
P/tB 5.93
EV/EBITDA 21.68
EPS(TTM)0.83
EY2.46%
EPS(NY)1.06
Fwd EY3.14%
FCF(TTM)1.59
FCFY4.71%
OCF(TTM)1.72
OCFY5.08%
SpS6.51
BVpS16.48
TBVpS5.7
PEG (NY)1.47
PEG (5Y)N/A
Graham Number17.5437 (-48.1%)
Profitability
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROCE 5.82%
ROIC 4.59%
ROICexc 6.63%
ROICexgc 80.43%
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
FCFM 24.49%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.19%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 136.72%
Profit Quality 190.84%
Current Ratio 8.15
Quick Ratio 7.81
Altman-Z 16.87
F-Score8
WACC9.19%
ROIC/WACC0.5
Cap/Depr(3y)43.31%
Cap/Depr(5y)38.08%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y27.72%
EPS Next 2Y22.38%
EPS Next 3Y19.54%
EPS Next 5Y21.22%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
Revenue Next Year13.07%
Revenue Next 2Y12.7%
Revenue Next 3Y11.91%
Revenue Next 5Y10.74%
EBIT growth 1Y301.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year206.27%
EBIT Next 3Y58.21%
EBIT Next 5Y37.52%
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.51%
OCF growth 3Y162.45%
OCF growth 5YN/A

VERACYTE INC / VCYT Fundamental Analysis FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 7 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 5 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


Can you provide the profitability details for VERACYTE INC?

VERACYTE INC (VCYT) has a profitability rating of 7 / 10.


Can you provide the financial health for VCYT stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.